Medical News Today: How does bereavement impact the immune system?

Losing a loved one increases the risk of mortality. A recent review investigates whether changes to the immune system might help explain this effect.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Related Links:

Publication date: Available online 15 April 2019Source: Veterinary Immunology and ImmunopathologyAuthor(s): Wolfgang SiposAbstractIn mammals, the immune system is undergoing significant changes during development, which has many impacts on the individual’s capacity to cope with infectious diseases or other pathologic conditions, where the immune system is involved. Especially in livestock, it is important to know in detail about these changes, including shifts in the composition of systemic leukocyte populations, as this knowledge may help to focus on relevant cell populations when developing novel vaccines for use i...
Source: Veterinary Immunology and Immunopathology - Category: Veterinary Research Source Type: research
The objective of this study was to collect stakeholder feedback on access and utilization of CDSi from the Minnesota Immunization Information Connection (MIIC), Minnesota's IIS. Input was solicited using a semi-structured questionnaire developed by experts, and from a sample of 17 key informants from February 2015 through May 2016. Analysis highlighted the appreciation of MIIC services, comprehensive vaccination history across providers and CDSi functionality, with public health users relying on MIIC. It also identified issues such as data entry due to read-only view, data quality and communications for improvement. These ...
Source: AMIA Annual Symposium Proceedings - Category: Bioinformatics Tags: AMIA Annu Symp Proc Source Type: research
It only takes one scary true story to turn an already fearful parent off vaccines.
Source: Science - The Huffington Post - Category: Science Source Type: news
[Vanguard] United Nations, UN, yesterday said measles cases across the world rose by 300 per cent through the first three months of 2019 compared to the same period last year, as concerns grow over declining vaccination.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Conclusions: Antidengue NAb levels can be boosted to levels at least as high as, or higher than those observed after completion of the primary 3-dose series, with an additional dose of CYD-TDV 4–5 years after the standard 3-dose vaccination schedule.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Vaccine Reports Source Type: research
Conclusions: RV vaccination using RotaTeq did not alter the occurrence of DM1 but decreased the prevalence of CD in childhood and adolescence. We propose that wild-type RV may trigger CD and the triggering effect can be prevented or reduced by RV vaccination.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Vaccine Reports Source Type: research
Conclusions: From 2011 to 2016, influenza-associated SARI hospitalization rates in children aged younger than 5 years of age in Suzhou, China, were high, particularly among children 0–5 months of age. Higher hospitalization rates were observed in years where the predominant circulating virus was influenza A/H3N2. Immunization for children> 6 months, and maternal and caregiver immunization for those
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Original Studies Source Type: research
A total of 555 measles cases have occurred this year, surpassing 372 last year and approaching 667 in 2014, according to the CDC. Vaccination refusal is the primary driver of the disease outbreaks.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
[The Herald] Government, with support from UNICEF, will start rolling out mass cholera vaccination in Chimanimani and Chipinge today targeting about 500 000 people.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
The Epstein-Barr virus (EBV) is one of the predominant tumor viruses in humans, but so far no therapeutic or prophylactic vaccination against this transforming pathogen is available. We demonstrated that heterologous prime-boost vaccination with the nuclear antigen 1 of EBV (EBNA1), either targeted to the DEC205 receptor on DCs or expressed from a recombinant modified vaccinia virus Ankara (MVA) vector, improved priming of antigen-specific CD4+ T cell help. This help supported the expansion and maintenance of EBNA1-specific CD8+ T cells that are most efficiently primed by recombinant adenoviruses that encode EBNA1. These c...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
More News: Health | Vaccines